|
|
|
| Surgical portosystemic shunts to facilitate major intrabdominal
surgery |
| Michail Pizanias ∗, Elissaios Kontis, Evangelos Prassas, Parthi Srinivasan, Andreas Prachalias |
Department of Liver Transplantation, Hepatobiliary Pancreatic Surgery, King’s Healthcare Partners, King’s College Hospital NHS FT, Institute of Liver Studies,
Denmark Hill, London SE5 9RS, UK
∗ Corresponding author.
E-mail address: m.pizanias@nhs.net (M. Pizanias). |
|
|
|
|
Abstract The effective management of patients with chronic liver disease (CLD) and portal hypertension (PHT) has significantly prolonged their survival. Hence, there is an emerging number of patients who will require major elective intrabdominal surgery for reasons unrelated to their CLD (e.g., colorectal cancer). This group of patients represent high-risk surgical procedure due to their CLD, namely liver decompensation. To this end, alleviation of PHT is the most effective option of decreasing the risk of liver-related morbidity, either with surgical portosystemic shunts (SPS) or transjugular intrahepatic portosystemic shunt (TIPS). We present the short-term outcomes of a case series of 7 consecutive patients with established CLD and PHT, who underwent a concomitant SPS to facilitate major intraabdominal surgery. The short-term outcomes of SPS are presented and the current indications are reviewed.
|
|
|
|
|
|
| [1] |
Jin LM, Zhang YH, Zhang CW, Wu WD, Wu J, Dou CW, Wei FQ, Wang ZF, Hu ZM, Zheng SS. Is laparoscopic radical cholecystectomy an effective and safe approach for advanced gallbladder cancer?[J]. Hepatobiliary Pancreat Dis Int, 2020, 19(3): 203-204. |
|
|
|
|
2019, Vol. 18 
